Comparison of the medical costs between active surveillance and other treatments for early prostate cancer in Japan using data from the PRIAS-JAPAN study.
Kato T, Yokomizo A, Matsumoto R, Tohi Y, Miyakawa J, Mitsuzuka K, Sasaki H, Inokuchi J, Matsumura M, Sakamoto S, Kinoshita H, Fukuhara H, Kamiya N, Kimura R, Nitta M, Okuno H, Akakura K, Kakehi Y, Sugimoto M.
Kato T, et al. Among authors: sugimoto m.
Int J Urol. 2022 Nov;29(11):1271-1278. doi: 10.1111/iju.14977. Epub 2022 Jul 19.
Int J Urol. 2022.
PMID: 35855586